The ROC curve of the diagnostic ability of the five tumor markers (APT, CA-125, CA-199, CA-153, and CEA) for screening for breast cancer was drawn, with the benign breast nodule and healthy control participants as the control group and breast cancer patients as the case group (Table 2, Fig. 2). This evidence concerns the gene CEACAM5 and neoplasm.